Home   >  
GPCR/G Protein
  >  
Angiotensin Receptor
  >   AVE 0991 sodium salt
AVE 0991 sodium salt Chemical Structure

AVE 0991 sodium salt

Data Sheet For research use only. Not for human use.
Cat. No. :BCP11068CAS No. :306288-04-0Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 306288-04-0 Cat. No. BCP11068
Name AVE 0991 sodium salt
Synonyms AVE0991 sodium salt;AVE-0991 sodium salt;
SMILES
Chemical Name
Formula C29H31N4NaO5S2 M. Wt 602.7
Purity 98% Storage Store at 4-8°C
Description in vivo: In water-loaded C57BL/6 mice, AVE 0091 (0.58 nmol/g body weight) produced a significant reduction in urinary volume (0.06+/-0.03 mL/60 min [n=9] versus 0.27+/-0.05 [n=9]; P<0.01), associated with an increase in urinary osmolality [2]. In normal hearts, AVE-0991 produced a significant decrease in perfusion pressure and an increase in systolic tension, rate of tension rise and fall (+/-dT/dt), and heart rate. These effects were completely blocked by the perfusion of the hearts with a solution containing the selective ANG-(1-7) antagonist A-779. N(G)-nitro-l-arginine methyl ester treatment abolished the AVE-0991-induced vasodilation in isolated hearts. AVE-0991significantly attenuated the decrease in systolic tension (sham operated, 13.00 +/- 1.02 g; infarction, 7.18 +/- 0.66 g; AVE treated, 9.23 +/- 1.05 g, n = 5), +dT/dt, -dT/dt, and heart rate induced by myocardial infarction. Infarction-induced vasoconstriction was completely prevented by AVE-0991treatment.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:AVE 0991 sodium salt supplier,AVE 0991 sodium salt purchase,AVE 0991 sodium salt manufacturer,AVE 0991 sodium salt distributor,AVE 0991 sodium salt cost,AVE 0991 sodium salt buy,AVE 0991 sodium salt for sale

0086-13720134139